Abstract

Diabetes is a highly complex disease. Despite many different pharmacological alternatives to treat diabetes, they simply slow the illness's progression. Once installed, it becomes a pathology that cannot be cured. Its significant growth worldwide makes it challenging for governments to manage the high costs of treating people suffering from diabetes. Many research investigations are carried out, and prominent pharmaceutical corporations emphasize the creation of novel medicines. The present lifestyles, diets, and sedentary behavior of the population have exacerbated the disease. Diabetes must find new approaches for new studies and methodologies focusing on the pathometabolic signaling and early manifestations of hyperglycemia.

Keywords

diabetes mellitus, insulin receptor, hyperglycemia, metabolic signaling